Ieva Sadzeviciene

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Prognostic Factors

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ieva Sadzeviciene, Kristina Snipaitiene, Asta Scesnaite-Jerdiakova, Kristina Daniunaite, Rasa Sabaliauskaitė, Aida Laurinaviciene, Monika Drobniene, Valerijus Ostapenko, Sonata Jarmalaite
Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases. International journal of molecular sciences 23 (23) (2022)
Ieva Sadzeviciene, Kristina Snipaitiene, Asta Scesnaite-Jerdiakova, Kristina Daniunaite, Rasa Sabaliauskaitė, Aida Laurinaviciene, Monika Drobniene, Valerijus Ostapenko, Sonata Jarmalaite
Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases. International journal of molecular sciences 23 (23) (2022)
Ieva Sadzeviciene, Kristina Snipaitiene, Asta Scesnaite-Jerdiakova, Kristina Daniunaite, Rasa Sabaliauskaitė, Aida Laurinaviciene, Monika Drobniene, Valerijus Ostapenko, Sonata Jarmalaite
Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases. International journal of molecular sciences 23 (23) (2022)
Ieva Sadzeviciene, Kristina Snipaitiene, Asta Scesnaite-Jerdiakova, Kristina Daniunaite, Rasa Sabaliauskaitė, Aida Laurinaviciene, Monika Drobniene, Valerijus Ostapenko, Sonata Jarmalaite
Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases. International journal of molecular sciences 23 (23) (2022)
Ieva Sadzeviciene, Kristina Snipaitiene, Asta Scesnaite-Jerdiakova, Kristina Daniunaite, Rasa Sabaliauskaitė, Aida Laurinaviciene, Monika Drobniene, Valerijus Ostapenko, Sonata Jarmalaite
Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases. International journal of molecular sciences 23 (23) (2022)